Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 30, 2025
FSR Celebrates Congressional Recognition of April as Sarcoidosis Awareness Month
GlobeNewswire
·
April 30, 2025
CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) today celebrated the official recognition of April as Sarcoidosis Awareness Month in the U.S. House of Representatives, a meaningful milestone that coincides with the …
Best Probiotic for Women Weight Loss and Vaginal Health - Top Women's Probiotic Supplement for Constipation and Gut Health - YourBiology
GlobeNewswire
·
April 30, 2025
Glasgow, April 30, 2025 (GLOBE NEWSWIRE) -- Are you searching for the best probiotics for women's weight loss and vaginal health? Did you know your gut and vaginal health are closely connected? This "gut-vagina axis" plays a pivotal role in your overall …
Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
GlobeNewswire
·
April 30, 2025
PALO ALTO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
FDA Approves Johnson & Johnson’s IMAAVYTM (nipocalimab-aahu) a New Treatment for Myasthenia Gravis (MG), Offering Hope for Families
GlobeNewswire
·
April 30, 2025
New York, April 30, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) applauds the U.S. Food and Drug Administration (FDA) approval of IMAAVYTM (nipocalimab-aahu) for the treatment of people ages 12 and older who are living with antibody …
Specialists Eye Gazyva as a New Option for Lupus Nephritis, but ACR Guidelines Favor Benlysta and Lupkynis for Upfront Use, According to Spherix Global Insights
GlobeNewswire
·
April 30, 2025
EXTON, PA, April 30, 2025 (GLOBE NEWSWIRE) -- The American College of Rheumatology’s (ACR) newly updated treatment guidelines for lupus nephritis (LN) have led specialists to reconsider their treatment approaches, particularly around the use of triple …
Make Asthma and Allergy Treatments Accessible for All
GlobeNewswire
·
April 30, 2025
Washington, DC, April 30, 2025 (GLOBE NEWSWIRE) -- This year, the Asthma and Allergy Foundation of America (AAFA) continues a tradition started in 1984 - designating May as National Asthma and Allergy Awareness Month. Our focus for 2025: Make asthma and …
Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
GlobeNewswire
·
April 30, 2025
New York, USA, April 30, 2025 (GLOBE NEWSWIRE) -- Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight In recent years, the treatment landscape of HR+/HER2−ve breast cancer has completely …
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
GlobeNewswire
·
April 30, 2025
CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Press Release: Annual General Meeting of April 30, 2025
GlobeNewswire
·
April 30, 2025
Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024 Distribution of a cash dividend of €3.92 per share, with payment as of May 14, 2025 Board composition: renewal of four Directors and ratification of the …
Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2025
GlobeNewswire
·
April 30, 2025
Assemblée Générale Annuelle du 30 avril 2025 Approbation des comptes sociaux et des comptes consolidés de l’exercice 2024 Distribution d’un dividende en numéraire de 3,92 euros par action, dont la mise en paiement interviendra le 14 mai 2025 Composition du …
Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
GlobeNewswire
·
April 30, 2025
EXTON, PA, April 30, 2025 (GLOBE NEWSWIRE) -- As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how specialists are currently managing the condition—and where emerging …
Strengthening Global Pandemic Preparedness: The Urgent Need for Investment, Collaboration, and Action
GlobeNewswire
·
April 30, 2025
TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN) is highly concerned that the world is unprepared for the next pandemic and has not incorporated the lessons learned from COVID-19. The GVN, comprised of 80+ Virology Centers of …
Best Probiotics for Bloating and Gas 2025: Top Probiotic Gut Health Supplements from YourBiology
GlobeNewswire
·
April 30, 2025
GLASGOW, United Kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- YourBiology Gut+ is the best probiotic for bloating, gas, and constipation—powered by Lactobacillus, Bifidobacterium, prebiotics, enzymes, and Vitamin D3 to improve gut health, digestion, and …
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
GlobeNewswire
·
April 30, 2025
EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in …
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
GlobeNewswire
·
April 30, 2025
KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC), a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it has received official notification …
NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA
GlobeNewswire
·
April 30, 2025
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to alcohol during gestation to receive treatment with the …
Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation
GlobeNewswire
·
April 30, 2025
FINDLAY, Ohio, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Understanding Nerve Pain and the Promise of Arialief Millions of people worldwide suffer silently from nerve pain — a condition that slowly steals mobility, independence, and quality of life. …
WellSpan Surgery and Rehabilitation Hospital reaccredited with top Magnet designation
GlobeNewswire
·
April 30, 2025
York, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- WellSpan Surgery and Rehabilitation Hospital in York has been reaccredited as a Magnet hospital, the highest honor for nursing, awarded by the American Nurses Credentialing Center (ANCC). As part of the …
Spark Biomedical Secures $15M Series A To Advance Drug-Free Wearable Neurostimulation Therapies
GlobeNewswire
·
April 30, 2025
Dallas, TX, April 30, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round—led by WAVE Ventures and supported by Pathway to Cures—to accelerate the …
X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate
GlobeNewswire
·
April 30, 2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded collaboration with Orion Pharma. The agreement builds on an existing relationship …